Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

Healthcare Industrials Auto Parts Diversified Industrials
HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:HLS)

HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire 9 days ago

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

Canada NewsWire 10 days ago

HLS Therapeutics Announces Fiscal 2023 Financial Results

Canada NewsWire March 14, 2024

HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call

Canada NewsWire February 29, 2024

HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan

Canada NewsWire February 6, 2024

HLS Therapeutics Announces CFO Departure

Canada NewsWire December 18, 2023

New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline

Canada NewsWire November 14, 2023

HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results and Renewal of Normal Course Issuer Bid

Canada NewsWire November 9, 2023

HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call

Canada NewsWire October 26, 2023
View More News ››

Opinion & Analysis (TSX:HLS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:HLS)

BC Drug Plan

Discussion boards are dead everywhere I can see, but the reimbursement from BC is big news. Last March, when it was announced that...
screamer99 - February 6, 2024

RE:not just one but two cantechletter.com articles

Thanks for posting this.
Imlearning - June 12, 2023

not just one but two cantechletter.com articles

May provide a volume lift ? HLS Therapeutics is still a buy, says Stifel It’s been a rough ride these past two years for fans of...
Possibleidiot01 - June 12, 2023

Dividend

Expecting a dividend cut tomorrow. Poorly managed co. avoid at all cost
Pat123 - May 10, 2023

RE:Anyone following HLS still?

IMO the stock is dirt cheap.  Valuation is less now than when they went public.  At that time the stock valuation was primarily...
microcaptt - April 17, 2023

Anyone following HLS still?

BB activity really petered out here. I am still curious about this company, and I note some analysts are still expecting big things from...
rational - April 17, 2023
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ...
View More »